Notícias

Active immunization with the BNT162b2 vaccine (Pfizer–BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2...

Coronavirus disease 2019 (COVID-19) is especially severe in aged populations1. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are...

Webinar debate estímulo à indústria nacional da biodiversidade

Jacqueline Duarte

O termo IFA ficou mundialmente conhecido durante a pandemia de Covid-19, os Insumos Farmacêuticos Ativos também conhecidos como...

In January, 2021, a vaccination campaign against COVID-19 was initiated with the rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines in Argentina....

Antonio Carlos Bezerra, presidente executivo da ABIFINA, representou a entidade em reunião da Frente Parlamentar da Indústria Pública de Medicamentos,...

Setor conhece nova secretária de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde

Antonio Carlos Bezerra, presidente executivo da ABIFINA,...

Fernanda Costa, coordenadora de Comércio Exterior e Cadeia Química da entidade, acompanhou a reunião da Coalizão Empresarial Brasileira (CEB) da...

Waning of vaccine protection against coronavirus disease 2019 (Covid-19) and the emergence of the omicron (or B.1.1.529) variant of the...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with...

ABSTRACT: In the past 2 years, the coronavirus disease 2019 (COVID-19) pandemic has driven investigational studies and controlled clinical trials...

Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 ...